Coretox is a botulinum toxin type A made by Medytox in South Korea, sold as a lyophilized white powder in a 100-unit vial. Its distinctive feature is that it is a 150 kDa “complex-free” pure neurotoxin without accessory proteins, and free of animal-derived ingredients. The official guide is below for your records.
What is Coretox, and what does “complex-free” mean?
Coretox is a 100-unit, freeze-dried botulinum toxin type A from Medytox. Many toxins contain the core neurotoxin bound to a cluster of accessory proteins (such as hemagglutinins), forming a larger complex around 900 kDa. Coretox strips those away. It is a roughly 150 kDa pure neurotoxin, marketed as “complex-free,” and it is also made without animal-derived ingredients.
The manufacturer’s rationale is that fewer accessory proteins may mean a lower chance of developing resistance or neutralizing antibodies over repeated use. Frame that as a theory and a design philosophy, not a proven outcome. Coretox is stored at 2 to 8°C. The complex-free approach contrasts with complex-containing toxins like Puritox and Toxpia, which keep the complete 900 kDa complex.
Log Notes. This explains what Coretox is and its complex-free design, not how to use it. It gives no doses, units, dilution, injection points, depth, or frequency, all of which live in the official guide and belong to a licensed professional. Nothing here is medical advice, and this is not a do-it-yourself procedure.
How does botulinum toxin type A work?
It temporarily relaxes the targeted muscle. Whether complex-free or complex-bound, botulinum toxin type A acts by blocking acetylcholine release at the neuromuscular junction, the signal that makes a muscle contract. Published reviews of the mechanism of botulinum toxin type A describe how interrupting that signal relaxes the muscle for a period before nerve signaling gradually returns.
The accessory proteins are not what does the relaxing; the core neurotoxin is. That is why two design philosophies exist. Complex-free products bet on potentially lower immunogenicity, while complex-containing products keep the traditional formulation. Whether the complex-free theory translates into a meaningful real-world difference is debated and not settled, so treat the antibody rationale as a hypothesis a professional can weigh, not a guarantee.
What should you expect, and what is worth tracking?
A clear arc and a steady record. The relaxing effect builds over days, then fades over weeks to months, so session-to-session comparison is what reveals the pattern. If resistance over repeated cycles is on your mind, that is exactly the kind of long timeline worth documenting honestly, and exactly the kind a professional should review.
What is worth tracking here? Begin with how long results lasted for you across each cycle. Reported averages come from groups of people, and your personal duration may sit higher or lower. Note when the effect began to fade and count back to your last session to find your own range, then watch whether that range holds over time.
Photos matter, but only consistent ones. Keep the same angle, the same lighting, and a neutral expression each time, ideally at a similar hour. A matched before-and-after pair tells you more than memory or a good-mirror moment. With the complex-free, low-immunogenicity question in play, a long and steady photo trail is especially worth keeping.
Add a self-rating before each next appointment and always record which brand was used. A quick score on how relaxed the area still feels, plus a note on whether you would repeat the plan, gives a professional something concrete to weigh. If you ever switch products, that brand note is what makes a fair comparison possible later.
This is the cycle Dosefi is built to track. Add Coretox as a treatment, log each session with a date and photo, set a reminder for when results tend to ease, and let your self-rated notes build a trend across cycles. For context, see what Botox can do and the sibling note on Innotox.
A grounded takeaway
Coretox is Medytox’s 150 kDa complex-free, animal-free botulinum toxin type A, designed around a low-immunogenicity rationale that remains a theory rather than a settled fact. Keep a dated record over multiple cycles, and leave candidacy, dosing, product choice, and the procedure to a licensed professional. The official guide is attached for your reference.
Sources
- “Botulinum Toxin Type A” pharmacology review (PMC). Peer-reviewed overview of how botulinum toxin type A blocks acetylcholine release at the neuromuscular junction.
